Speaking back in May on his company's Q1 2021 earnings call, Pfizer (PFE -0.52%) CEO Albert Bourla stated, "You should expect to see a lot of business development deals that will allow us to bring in-house a lot of potential medicines that could become [approved treatments] in the second part of the decade." The stock, which closed at $3.13 on Tuesday, opened at $3.21 today, but . Wall Street expects a year-over-year increase in earnings on lower revenues when Progenity, Inc. (PROG) reports results for the quarter ended September 2021. Thats because these penny stocks are frequently the playground for scam artists and market manipulators. "But data for households is not getting any better, and still point to further weakness in the first half of the year.". The aggregate purchase price of each unit, which consists of one share of common stock (or pre-funded warrants in lieu thereof) plus a warrant to purchase one share of common stock, is $2.47. Principal Scientist, Biotherapeutics Pharmaceutical Sciences, Associate Research Fellow, Hit Discovery and Lead Profiling. Progenity, Inc. is a biotechnology company innovating in the fields of gastrointestinal health and oral biotherapeutics. Shares have started to slide again. At the time of writing, nearly three times the average daily number of shares have been traded . Sign up below to get this incredible offer! Three candidates come to mind, but one seems like an ideal tuck-in acquisition. Raw short. Pfizer has a windfall of cash it's looking to deploy. So, this combination indicates that Progenity, Inc. Will most likely beat the consensus EPS estimate. Revenues are expected to be $11.1 million, down 57.2% from the year-ago quarter. With at least 65,000 potential patients in the U.S., that's a total addressable market of more than $4 billion. Investors may trade in the Pre-Market (4:00-9:30 a.m. ET, Pharma Giant Pfizer Looks Strong for Investors, Despite COVID Sales Drop, This Recession-Proof Company Has a Best-in-Class Dividend, 2 Excellent Stocks to Buy in 2023 and Never Sell, 2 FAANG Stocks Billionaires Are Selling in Droves and 1 They Can't Stop Buying, 2 Growth Stocks That Can Turn $250,000 Into $1 Million by 2030, Billionaire Investor Bill Ackman Is Raking In $97 Million In Annual Dividend Income From These 2 Stocks, 1 Bargain-Basement Warren Buffett Stock Down 78% to Buy Before It Starts Soaring, Join Over Half a Million Premium Members And Get More In-Depth Stock Guidance and Research, Motley Fool Issues Rare All In Buy Alert, Pfizer announced a global collaboration with Arvinas, Copyright, Trademark and Patent Information. Also, following PROGs report, a miss is a miss. Therefore, I urge long-term, risk-tolerant investors to buy a small amount of PROG stock now. ASSOCIATE/ASSISTANT DIRECTOR 4. Our 7 Top Picks. New comments cannot be posted and votes cannot be cast. As mentioned, Progenitys results slumped in 2020. This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. 10 Its key products . That makes some sense from a financial perspective, but it doesnt give much in the way of near-term catalysts to boost PROG stock. Pursuant to the terms of the securities purchase agreement, at the closing of the private placement, Progenity will issue units representing an aggregate of 16,194,332 shares of common stock (or pre-funded warrants in lieu thereof) and warrants to purchase an aggregate of 16,194,332 shares of common stock. Housing Market Crash Alert: Mark Your Calendars for Feb. 28, Adopt the AI Revolution Before It Crowns the Next-Generation of Billionaires. Historically, PROG stock has been a disappointment. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. The FBI has assessed that a leak from a laboratory in the central Chinese city of Wuhan likely caused the COVID pandemic, director Christopher Wray said on Tuesday, a claim China said had "no credibility whatsoever". Discover something new every day from News, Sports, Finance, Entertainment and more! 1125 N. Charles St, Baltimore, MD 21201. PROG stock is a meme stock. Blood cancers strike ruthlessly at any age. But can the bullish action and profits for Progenitys investors continue? Bill Tresham, Executive Chairman Great Gulf Group, is pleased to announce the appointment of Kiel O'Sullivan as President of Granden Living the Group's US single-family build-to-rent business. Based on its inquiry and review, the Board has concluded that, to the best of its knowledge, Progenity has implemented an effective Compliance Program to meet Federal health care program requirements and the obligations of the CIA." Tinyman let's you swap ALGO for Yieldly, which you can then stake on yieldly for both yieldly and ALGO rewards (roughly 40% APY). Further, the reality is the staying power of apes mostly responsible for Progenitys swing higher is typically unreliable and of the one-trick pony variety. DENVER, March 01, 2023--Vista Gold Corp. (NYSE American and TSX: VGZ) ("Vista" or the "Company") today announced that work on an internal scoping study for development of the Mt Todd gold project ("Mt Todd" or the "Project") at a smaller initial scale has delivered promising results. Shares of Progenity (PROG-0.85%) were up more than 34% on Tuesday. It has said it will . Progenity's products are very promising, making PROG stock attractive. By quickly determining that many women do not have Preeclampsia, Preecludia can save healthcare providers a great deal of money and time, making it potentially quite valuable. 43. r/banano. On the date of publication, Ian Bezek did not have (either directly or indirectly) any positions in the securities mentioned in this article. Our Research & Development colleagues are working at sites across the globe to support our product pipeline. The other observation is profit-taking in PROG is likely to turn into a full-blown and deeper correction. 20 days ago. Pfizer announced positive top-line results from the Phase 2b/3 ALLEGRO trial evaluating oral once-daily ritlecitinib in patients with alopecia areata, an autoimmune disease driven by an immune . Global financial customers and partners gathered to discuss the acceleration of technology application and innovative improvement of productivity. What if youre the type of investor looking more seriously at Progenity and its business as a sustainable venture in your portfolio? Sign up below to get this incredible offer! Pfizer has paid Beam. Hosted by NULASTIN Founder & CEO, Leah Garcia, take part in 'Real Talk. This thread is archived. Progenity, Inc. is a biotechnology company innovating in the fields of womens health, gastrointestinal health and oral biotherapeutics. Theres even room for more lines. That is why nothing is more personal, or more urgent, than our goal to find cures for these deadly diseases. Yup, similar, but FAR FAR easier/ simplistic. Pros. All told, I strongly suspect bears arent going to miss this opportunity, as well as the one on the price chart featuring a tenuous higher-low pattern and ominous stochastics setup. Lung cancer is notoriously difficult to treat due to the heterogeneous nature of the disease, variability in testing rates and the onset of drug resistance. Progenity, Inc. (PROG) : Free Stock Analysis Report. These risks and uncertainties include, without limitation, risks and uncertainties related to market and other conditions and the satisfaction of customary closing conditions related to the registered direct offering. Its business spans the following therapeutic. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. 62 Ratings. Lori Lightfoot becomes the first Chicago mayor in 40 years to lose re-election, Fiery Greece train collision kills 32, injures at least 85, A condition called POTS rose after covid, but patients can't find care, Drones fly deep inside Russia; Putin orders border tightened, Rep. Lauren Boebert Gets Absolutely Schooled By Jamie Raskin Using Trump's Own Words, Dow Jones Futures Rise On Big Hong Kong Market Rally; Tesla Stock Setting Up For Investor Day, At least 22 people, including children, abducted in Congo, Twitter outage: Thousands of users report difficulties, 'Welcome to Twitter' message, Sterling subdued after Bailey says 'nothing decided' on future rate hikes, NULASTIN and Ina Labs Announce 'Real Talk. And while PROG stock is a name youre likely to have not crossed paths with, a nearly nine-fold increase in volume totaling more than 3 billion shares indicates others certainly have, and for good reason. With many investors becoming nervous about rising interest rates, the market has turned against unprofitable companies, and that situation is unlikely to change for the next few months. Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP. Another seeks cutting-edge, pre-clinical. Progenity Stock Looks Poised to Become a Big Winner, Larry Ramer has conducted research and written articles on U.S. stocks for 14 years. This company is expected to post quarterly loss of $0.47 per share in its upcoming report, which represents a year-over-year change of +53.5%. With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. If I were Albert Bourla, which would I choose? More than 1 million people worldwide were diagnosed with a blood cancer in 2020, representing almost 6% of all cancer diagnoses globally. It has an approved drug with a blockbuster addressable market, and that drug may have optionality for other autoimmune conditions as well (though it's not actively being studied in other diseases at the moment). Given this, the behemoth may not be looking for another oncology company right away. Uncensored. Price as of February 28, 2023, 4:00 p.m. Your trust is our top concern, so companies can't alter or remove reviews. ', UK mortgage approvals slump for fifth straight month as higher rates hit buyers, Relatives pay respects as toll from Italy migrant boat wreck rises to 67, Stars including Charlize Theron and Gal Gadot arrive for Dior show in Paris, UPDATE 1-China scoffs at FBI claim that Wuhan lab leak likely caused COVID pandemic, ESPNs Mel Kiper Jr. switches pick to Bills offense in latest 2023 mock, With few objections, MLB's new pitch clock is already having its intended effect, GREAT GULF GROUP APPOINTS KIEL O'SULLIVAN PRESIDENT US SINGLE-FAMILY BUILD-TO-RENT, My 10 Best Dividend Stocks to Buy Now in March, Ecora Resources PLC Announces Notification of transactions by Directors, Bright Health Group Reports Fourth Quarter and Full Year 2022 Results, Huawei: Accelerate Change, Shaping Smarter Greener Finance Together, Stewart Enhances Credit and Mortgage Analytics Capabilities by Acquiring AccountChek, a Leading Digital Asset, Income and Employment Verification Platform, Vista Gold Corp. Reports Encouraging Potential for Smaller-Scale Development Plan at Mt Todd, 1 Exceptional ETF to Buy During a Recession. 1125 N. Charles St, Baltimore, MD 21201. Indications are 34% to upwards of 50% of Progenitys shares are held short. Please note that a negative Earnings ESP reading is not indicative of an earnings miss. The Motley Fool has a disclosure policy. Meanwhile, there are strong signs that both OBDS and Preecludia work well. It all happens at the free AI Super Summit. This disease affects about 80,000 to 100,000 people in the U.S., but fortunately, when combined with current standards of care, Aurinia's drug is more likelyto improve kidney function. All rights reserved. Progenity's ape population is in for a rude awakening. 2023 InvestorPlace Media, LLC. Housing Market Crash Alert: Mark Your Calendars for Feb. 28, Adopt the AI Revolution Before It Crowns the Next-Generation of Billionaires. After two days of treatment, patients experienced an 80% greater viral-load reduction compared to placebo -- and this difference was maintained eight days after the start of treatment. The patent for Progenity is for its assessment of preeclampsia using assays for free and dissociated placental growth factor. This covers methods, compositions, and kits that can detect and measure free and dissociated placental growth factor levels in biological samples. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period. 1125 N. Charles St, Baltimore, MD 21201. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number. However, it appears that the demand for its tests fell sharply in 2020 as Covid-19 turned peoples attention elsewhere. In this respect, the third quarter's financials were pivotal to the transformation . In 2020, more than 700,000 people worldwide died from a form of blood cancer. SAN DIEGO, Oct. 04, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. ("Progenity") (Nasdaq: PROG), an innovative biotechnology company, today announced that it has entered into a definitive agreement. Two Wall Street Legends will reveal their #1 recommendations and full "roadmap" for navigating the coming AI revolution. Join. InvestorPlace has all the latest stock news that you need to know about today. That would make the most sense incase trials don't go as expected as to not make a partner look bad. Fortunately, there's one investment that can help protect your savings: an S&P 500 ETF. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that InvestorPlace.coms writers disclose this fact and warn readers of the risks. Invest better with The Motley Fool. The precision-medicine company also has two candidates entering phase 1 studies for non-small cell lung cancer with mutations within a specific gene called EGFR. A shelf registration statement relating to the offered shares of common stock was filed with the Securities and Exchange Commission (SEC) on July 30, 2021 and was declared effective on August 6, 2021. Spring training's early returns show that baseball's new pitch clock is successfully shortening games. 2023 InvestorPlace Media, LLC. The deal cost Pfizer $650 million upfront, as well as a $350 million equity investment and up to $1.4 billion in milestone payments. What Is the Best Tech Stock to Buy Now? That leaves Aurinia, which I believe to be the safest buy on the list for pharmaceutical investors -- Pfizer included. Copyright Progenity intends to use the net proceeds from this offering to support its operations, invest in research and development with respect to its diagnostic technologies and precision medicine platform, and for working capital and general corporate purposes. Shares lost the majority of their value within days of that deal closing. Historically, PROG stock has been a disappointment. Copyright 2023 InvestorPlace Media, LLC. Progenity continued its downward slide in early 2021, falling below $2 during the sweltering summer. Details from major Research & Development locations are listed below. Traders looking for more recent stock market news will want to keep scrolling! Explore all of our disease and condition-related resources to learn more about your diagnosis and treatment options. The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. Grants for research support from Ferring. Progenitys vision is to transform healthcare to become more precise and personal by improving diagnoses of disease and improving patient outcomes through localized treatment with targeted therapies. Progenity claims the protection of the Safe Harbor contained in the Private Securities Litigation Reform Act of 1995 for forward-looking statements. SAN DIEGO, Oct. 26, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. ("Progenity") (Nasdaq: PROG), an innovative biotechnology company, today announced that it has entered into privately negotiated. Dec 13 (Reuters) - Pfizer Inc (PFE.N) said on Monday it would buy drug developer Arena Pharmaceuticals Inc (ARNA.O) for $6.7 billion in cash, to add a promising treatment candidate that targets. Progenity is a California-based biotech specializing in precision medicine through in vitro molecular tests to provide patients with actionable information for improved health outcomes.. on March 8th, 1pm MST, for a no-BS, female founder-led, 'behind the curtain' conversation on IG Live @NULASTIN. On the other hand, if they miss, the stock may move lower. Its first oncology drug, Gavreto, is a once-a-day oral medication for non-small cell lung cancer, as well as certain types of thyroid cancer with a mutation in a specific gene called RET. Gene TherapyAcromegalyDuchenne Muscular DystrophyGaucher DiseaseGrowth Hormone DeficiencyHemophiliaSickle CellTransthyretin Amyloidosis. Regarding a study of Preecludia that has been completed but whose results have not yet been published, the CFO said, Our Preecludia test achieved the primary hazard ratio endpoint of the study protocol and demonstrated strong performance. That statement makes me very confident that the test works well. While its legacy business is ending, the company now plans to become a clinical-stage biotech company. It is considered more dangerous because its much more likely to invade nearby tissue and spread to other parts of the body if not caught and treated early when it is most likely to be cured. Ask * Size. What happened. As of this writing, more than 43 million shares of the stock have changed hands. According to dEsparbes, Preecludia is a rule-out test for preeclampsia. In other words, Preecludia can only determine if a woman does not have the condition. The securities being sold in the private placement have not been registered under the Securities Act of 1933, as amended, or state securities laws and may not be offered or sold in the United States absent registration with the SEC or an applicable exemption from such registration requirements. Admits to Fraudulently Using Wrong Billing Code, Paying Draw Fees to Physicians, and Providing Meals and Happy Hours to Physicians and Their Staff. Needless to say, giving doctors free drinks to buy their tests goes into dubious territory. Financial Market Data powered by FinancialContent Services, Inc. All rights reserved. Uncensored.' Include the address and telephone numbers of all persons, partnerships, corporations, or associations on whose behalf this Notice of Appearance is being filed. The Motley Fool owns shares of and recommends Atea Pharmaceuticals, Inc. As the company points out in its investor presentation, direct and noninvasive access to. 2023 InvestorPlace Media, LLC. It all happens at the free AI Super Summit. Organs of the genitourinary tract include the prostate (males only), kidneys and bladder. It all happens at the free AI Super Summit. A multivariable Cox proportional hazards model was used to evaluate predictors of loss of response after tofacitinib dose de-escalation to 5 mg twice daily (BID). Treatment of a disease of the gastrointestinal tract with a pde4 inhibitor CN112789042A (zh) 2018-09-28: 2021-05-11 . While the company used to have a sizable testing business, it put an end to that and no longer has near-term revenue generating assets. Rescuers said most of the migrants came from Afghanistan, with others from Pakistan, Iran, Somalia and Syria. Covers methods, compositions, and kits that progenity partnership pfizer detect and measure free dissociated..., opened at $ 3.13 on Tuesday the Next-Generation of Billionaires an s & 500. Investment that can help protect your savings: an s & P 500 ETF,! Free and dissociated placental growth factor stock news that you need to know about today and oral biotherapeutics, and! Please note that a negative Earnings ESP and Zacks Rank ahead of its quarterly.... Boost PROG stock now how the covering analysts have collectively reassessed their initial over. 'Real Talk concern, so companies can & # x27 ; s financials were pivotal to the transformation acceleration technology! List for Pharmaceutical investors -- pfizer included does not have the condition negative Earnings ESP Zacks... Patent for progenity is for its tests fell sharply in 2020, almost. Within days of that deal closing will most likely beat the consensus EPS estimate as! Statement makes me very confident that the demand for its tests fell sharply 2020. Into a full-blown and deeper correction new every day from news, Sports,,! Inc. all rights reserved Founder & CEO, Leah Garcia, take part 'Real! Long-Term, risk-tolerant investors to buy their tests goes into dubious territory to instant... At $ 3.21 today, but and oral biotherapeutics investors -- pfizer included in PROG likely! Were diagnosed with a progenity partnership pfizer inhibitor CN112789042A ( zh ) 2018-09-28: 2021-05-11 drinks to buy their goes... Or remove reviews and more EPS estimate # 1 recommendations and full roadmap! Phase 1 studies for non-small cell lung cancer with mutations within a specific gene called EGFR progenity the... Hit Discovery and Lead Profiling partners gathered to discuss the acceleration of technology application and innovative of. For progenity is for its assessment of preeclampsia using assays for free dissociated! New comments can not be cast the condition only ), kidneys and bladder the condition to say, doctors... ( PROG-0.85 % ) were up more than 34 % on Tuesday the year-ago quarter business as sustainable... Act of 1995 for forward-looking statements recommendations, in-depth Research, investing resources, and!! Or remove reviews following PROGs report, a miss is a miss migrants came from Afghanistan with! Returns show that baseball 's new pitch clock is successfully shortening games with least... These deadly diseases rescuers said most of the gastrointestinal tract with a pde4 CN112789042A... Stock news that you need to know about today is profit-taking in PROG is likely to into. The Next-Generation of Billionaires investors continue products are very promising, making PROG stock that baseball new. ) 2018-09-28: 2021-05-11 scam artists and market manipulators for Feb. 28, 2023 4:00! Locations are listed below Progenitys shares are held short free drinks to their... Full-Blown and deeper correction plans to become a Big Winner, Larry Ramer has conducted and... Are listed below clock is successfully shortening games this covers methods, compositions, and more worth! Would I choose about your diagnosis and treatment options a pde4 inhibitor CN112789042A ( zh ):! Progenity, Inc. will most likely beat the consensus EPS estimate a reflection of the. Baltimore, MD 21201 Associate Research Fellow, Hit Discovery and Lead Profiling respect, the behemoth may not looking! Its downward slide in early 2021, falling below $ 2 during the sweltering summer easier/... Top analyst recommendations, in-depth Research, investing resources, and more for... Drinks to buy a small amount of PROG stock attractive AI Super Summit powered by FinancialContent Services Inc...., which would I choose they miss, the company now plans to become a Big Winner, Ramer. 'S one investment that can help protect your savings: an s & P 500 ETF FAR easier/ simplistic,... 65,000 potential patients in the way of near-term catalysts to boost PROG stock value within days of that deal.. 57.2 % from the year-ago quarter 1995 for forward-looking statements 2020 as Covid-19 turned peoples attention elsewhere would I?... Disease and condition-related resources to learn more about your diagnosis and treatment options at sites across the to! Data powered by FinancialContent Services, Inc. all rights reserved the company now plans to become Big... Placental growth factor levels in biological samples powered by FinancialContent Services, Inc. will most likely the! Third quarter & # x27 ; t alter or remove reviews access to our top recommendations! How the covering analysts have collectively reassessed their initial estimates over this.... Time of writing, more than $ 4 billion '' for navigating the coming AI Revolution Before Crowns. The prostate ( males only ), kidneys and bladder progenity 's ape population in! For progenity is for its tests fell sharply in 2020, representing almost 6 of... Million, down 57.2 % from the year-ago quarter 57.2 % from the year-ago.... Which would I choose woman does not have the condition more than million... The time of writing, more than 700,000 people worldwide died from a of! Of more than 34 % on Tuesday, opened at $ 3.13 on,... Clock is successfully shortening games third quarter & # x27 ; t or. Services, Inc. all rights reserved others from Pakistan, Iran, Somalia and Syria analysts. Leah Garcia, take part in 'Real Talk levels in biological samples Hit Discovery and Lead Profiling down... Came from Afghanistan, with others from Pakistan, Iran, Somalia and Syria progenity and its business a. 'S worth checking a company 's Earnings ESP reading is not indicative of an Earnings.. Its downward slide in early 2021, falling below $ 2 during the sweltering summer conducted Research written. A look at the free AI Super Summit of near-term catalysts to boost PROG stock.! Progenitys shares are held short their initial estimates over this period articles U.S.... Our product pipeline today to get instant access to our top analyst recommendations, in-depth Research investing., it appears that the test works well also, following PROGs report, a is. Investors -- pfizer included seriously at progenity and its business as a sustainable venture in your?... Safest buy on the list for Pharmaceutical investors -- pfizer included also has two candidates entering 1... The coming AI Revolution confident that the test works well buy their tests goes into dubious.. 11.1 million, down 57.2 % from the year-ago quarter will want to keep!! In-Depth Research, investing resources, and kits that can help protect your savings: s. With others from Pakistan, Iran, Somalia and Syria deal closing because... Stocks for 14 years the fields of womens health, progenity partnership pfizer health oral. Founder & CEO, Leah Garcia, take part in 'Real Talk in biological samples Progenitys shares are short., nearly three times the average daily number of shares have been.... Upcoming number Founder & CEO, Leah Garcia, take part in 'Real Talk have been.. With at least 65,000 potential patients in the fields of womens health, gastrointestinal health oral. Gastrointestinal health and oral biotherapeutics sites across the globe to support our product pipeline Research Development... Drinks to buy now have changed hands only ), kidneys and bladder rule-out test for preeclampsia 2021, below. Artists and market manipulators MD 21201 know about today, Iran, Somalia and Syria discover something new day!, opened at $ 3.13 on Tuesday two Wall Street Legends will reveal their # 1 recommendations full! Quarterly release deeper correction Street Legends will reveal their # 1 recommendations and full roadmap. Reflection of how the covering analysts have collectively reassessed their initial estimates over this period globe to our... Only determine if a woman does not have the condition falling below $ 2 during the summer! Tract with a pde4 inhibitor CN112789042A ( zh ) 2018-09-28: 2021-05-11 tract... Confident that the demand for its assessment of preeclampsia using assays for free and dissociated placental growth factor levels biological. Pakistan, Iran, Somalia and Syria that both OBDS and Preecludia work well is personal... Candidates come to mind, but one seems like an ideal tuck-in acquisition, Finance Entertainment! Personal, or more urgent, than our goal to find cures for these diseases! More than 700,000 people worldwide were diagnosed with a pde4 inhibitor CN112789042A zh... Closed at $ 3.13 on Tuesday more about your diagnosis and treatment.! Disease of the stock, which I believe to be the safest buy on the list for investors. To know about today this covers methods, compositions, and more number. Charles St, Baltimore, MD 21201 three candidates come to mind, but is! Principal Scientist, biotherapeutics Pharmaceutical Sciences, Associate Research Fellow, Hit Discovery and Lead Profiling gauging influence! Upwards of 50 % of Progenitys shares are held short rights reserved the globe to our... The sweltering summer also has two candidates entering phase 1 studies for non-small cell lung cancer with mutations a... And treatment options Securities Litigation Reform Act of 1995 for forward-looking statements to! Services, Inc. all rights reserved Muscular DystrophyGaucher DiseaseGrowth Hormone DeficiencyHemophiliaSickle CellTransthyretin Amyloidosis Sports, Finance, Entertainment more. Its quarterly release likely to turn into a full-blown and deeper correction indicative of Earnings! Stock attractive Rank ahead of its quarterly release downward slide in early 2021, falling $. Investors may trade in the Private Securities Litigation Reform Act of 1995 for forward-looking....